PTGX EPS Estimates
Protagonist Therapeutics, Inc.
$136.28
-$2.21(-1.60%)
56
Overall
20
Value
90
Tech
60
Quality
Market Cap
$8.96B
Volume
679.04K
52W Range
$73.08 - $160.81
Target Price
$173.00
PTGX EPS estimates: the consensus estimate for Protagonist Therapeutics, Inc.'s current fiscal year is $4.22 per share. Quarterly and next-year EPS forecasts, growth estimates and revenue projections follow.
PTGX EPS Estimates
- EPS estimate, current quarter
- $2.19
- EPS estimate, next quarter
- $-0.65
- EPS estimate, current year
- $4.22
- EPS estimate, next year
- $-0.07
- EPS growth, 3-year
- +7.62%
| Fiscal year | EPS |
|---|---|
| 2025 | $-2.05 |
| 2024 | $4.47 |
| 2023 | $-1.39 |
| 2022 | $-2.60 |
| 2021 | $-2.71 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | PTGX | $136.28 | -1.6% | 679.04K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Protagonist Therapeutics, Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW